Latest News

Compound reverses symptoms of Alzheimer's disease in mice

Research in an animal model supports the potential therapeutic value of an antisense compound to treat Alzheimer's disease. The molecule also reduced inflammation in the part of the brain responsible for learning and memory. The article is the second mouse study that supports the potential therapeutic value of an antisense compound in treating Alzheimer's disease in humans.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • The significance of non-motor microtubule-associated protein in maintaining synaptic plasticity thorough a novel mechanism

  • Head injury patients develop brain clumps associated with Alzheimer?s disease

  • Neurobiological changes explain how mindfulness meditation improves health

  • Mesh-like scaffold is disordered in Alzheimer's-affected cells

  • Researchers home in on why female newborns are better protected from brain injury

  • First-of-its-kind study explains why rest is critical after a concussion

  • Aggression causes new nerve cells to be generated in the brain

  • Brain formation pattern shows why early trauma may leave no clues

  • More effective speech therapy approach for children with Down Syndrome

  • Brain volume changes after cognitive behavioral therapy

  •